Trials / Completed
CompletedNCT00956423
Comparison of Physical Activity Regimens as Treatments for Obstructive Sleep Apnea
Exercise: A Novel Treatment for Obstructive Sleep Apnea
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- University of South Carolina · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the efficacy of two different physical activity regimens as complementary or alternative treatment options for the treatment of obstructive sleep apnea. A secondary purpose of the study is to examine the effects of these activity regimens on various health consequences of obstructive sleep apnea, including blood pressure, systemic inflammation, and daytime functioning.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | moderate-intensity aerobic and resistance training | Individuals will complete four days of aerobic exercise of moderate intensity (60% of maximal VO2, approximated from heart rate). Duration of aerobic activity will gradually increase from weeks 1 through 4 until 180 min of aerobic exercise at the prescribed intensity is performed each week. Following aerobic exercise on two days per week, moderate-intensity resistance training will be performed using eight different resistance machines. One set of 8-12 repetitions will be performed during weeks 1-4; from week 5-on, 2 sets of 8-12 repetitions will be performed. |
| BEHAVIORAL | low-intensity stretching | Individuals will perform supervised whole-body flexibility exercises on two days per week. Two sets of each exercise will be performed, with the duration of each stretch gradually increasing from 15 sec to 30 sec. A total of 15-20 stretches, focusing on whole-body flexibility, will be performed. |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2009-08-11
- Last updated
- 2011-11-24
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00956423. Inclusion in this directory is not an endorsement.